Trial Outcomes & Findings for Use of Whole Body Vibration in Patients With Fibromyalgia (NCT NCT03782181)
NCT ID: NCT03782181
Last Updated: 2020-02-13
Results Overview
Pressure stimuli were applied on two bilateral body locations: epicondyles and index finger. The pressure pain threshold was defined as the pressure value considered as painful by the participant.
COMPLETED
NA
40 participants
20 minutes
2020-02-13
Participant Flow
Participant milestones
| Measure |
Whole Body Vibration Plat
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform.
|
Control Group
No intervention arm
|
|---|---|---|
|
Overall Study
STARTED
|
20
|
20
|
|
Overall Study
COMPLETED
|
20
|
20
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Use of Whole Body Vibration in Patients With Fibromyalgia
Baseline characteristics by cohort
| Measure |
Patients Perform Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform.
|
Control Group
n=20 Participants
No intervention arm
|
Total
n=40 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
20 Participants
n=99 Participants
|
20 Participants
n=107 Participants
|
40 Participants
n=206 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Sex: Female, Male
Female
|
19 Participants
n=99 Participants
|
18 Participants
n=107 Participants
|
37 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
1 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
3 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
20 Participants
n=99 Participants
|
20 Participants
n=107 Participants
|
40 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Region of Enrollment
Spain
|
20 participants
n=99 Participants
|
20 participants
n=107 Participants
|
40 participants
n=206 Participants
|
|
weight
|
67 kg
STANDARD_DEVIATION 7.46 • n=99 Participants
|
65 kg
STANDARD_DEVIATION 5.82 • n=107 Participants
|
66 kg
STANDARD_DEVIATION 6.42 • n=206 Participants
|
PRIMARY outcome
Timeframe: 20 minutesPopulation: Patients diagnosed with fibromyalgia according to the criteria of the American College of Rheumatology (n=40).
Pressure stimuli were applied on two bilateral body locations: epicondyles and index finger. The pressure pain threshold was defined as the pressure value considered as painful by the participant.
Outcome measures
| Measure |
Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform, on January 18, 2017
|
Control Group
n=20 Participants
No intervention arm
|
|---|---|---|
|
Pressure Pain Thresholds
|
29.8 Newton/centimeter² (N/cm²)
Standard Deviation 9.7
|
22.1 Newton/centimeter² (N/cm²)
Standard Deviation 6.2
|
PRIMARY outcome
Timeframe: 20 minutesPopulation: Patients diagnosed with fibromyalgia according to the criteria of the American College of Rheumatology (n=40).
Vibration thresholds at the great toes and at the index fingers were quantified bilaterally using a Vibratron II (Physitemp, Clifton, USA). Using a two-alternative forced-choice procedure, subjects identified which of two rods was vibrating. Vibration values displayed on the control unit are vibration units (the amplitude of vibration, proportional to the square of applied voltage). Vibration threshold for the index finger in the normal population between 18 and 65 years of age is 0.7 vibration units with a standard deviation of 0.4 vibration units. The vibration threshold for the great toe in a similar population is 1.2 vibration units with a standard deviation of 0.5 vibration units. There is an increase in threshold scores and in variance as a function of age. There is an increase in threshold scores and variance depending on age. When the vibratory threshold is lower, it indicates the patient's greater ability to detect vibratory stimuli.
Outcome measures
| Measure |
Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform, on January 18, 2017
|
Control Group
n=20 Participants
No intervention arm
|
|---|---|---|
|
Vibration Thresholds
|
2.8 Hertz
Standard Deviation 0.7
|
3.5 Hertz
Standard Deviation 0.6
|
PRIMARY outcome
Timeframe: 30 minutesPopulation: Patients diagnosed with fibromyalgia according to the criteria of the American College of Rheumatology (n=40).
This is a functional balance assessment tool, consisting of 14 functional tasks with values ranging from 0 (cannot perform) to 4 (normal performance). The general scores range from 0 (severely impaired balance) to 56 (excellent balance). The Berg scale has been previously used in patients with fibromyalgia to assess balance.
Outcome measures
| Measure |
Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform, on January 18, 2017
|
Control Group
n=20 Participants
No intervention arm
|
|---|---|---|
|
Berg Scale
|
39.1 units on a scale
Standard Deviation 4.8
|
28.4 units on a scale
Standard Deviation 3.1
|
PRIMARY outcome
Timeframe: 6 minutesPopulation: Patients diagnosed with fibromyalgia according to the criteria of the American College of Rheumatology (n=40).
The 6MWT is a functional test in which the patient walks what he can during 6 minutes, analyzing the total distance walked.
Outcome measures
| Measure |
Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform, on January 18, 2017
|
Control Group
n=20 Participants
No intervention arm
|
|---|---|---|
|
Six-minute Walking Test (6MWT)
|
415 Metres
Standard Deviation 26.1
|
387 Metres
Standard Deviation 42.8
|
PRIMARY outcome
Timeframe: 5 minutesPopulation: Patients diagnosed with fibromyalgia according to the criteria of the American College of Rheumatology (n=40).
A back muscle dynamometer was used to measure isometric back muscle strength.
Outcome measures
| Measure |
Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform, on January 18, 2017
|
Control Group
n=20 Participants
No intervention arm
|
|---|---|---|
|
Dynamometer
|
40.8 Newtons.
Standard Deviation 5.9
|
32.8 Newtons.
Standard Deviation 4.8
|
PRIMARY outcome
Timeframe: 1 minutePopulation: Patients diagnosed with fibromyalgia according to the criteria of the American College of Rheumatology (n=40).
The CvMob is an Open Source tool for the movement analysis. The software is capable to analyse the trajectories and to determinate the kinematic variables from a movie, that can be done with a simple camera. The tool includes the Movement Elements Decomposition Method (MED).In the present study, we analyzed the oscillatory body movements during the test performance. These ocillatory movements should be minimal with good balance.The patients were asked to remain in orthostatic position with feet parallel at shoulder height, arms extended along the body and eyes closed for 1 minute. A body marker is placed on the patient's head. A camera placed on the ceiling records the movements. Subsequently, the software analyzes and decomposes the movement that the patient has described in the anteroposterior and mediolateral axis. Higher values represent a worse outcome.
Outcome measures
| Measure |
Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform, on January 18, 2017
|
Control Group
n=20 Participants
No intervention arm
|
|---|---|---|
|
Analysis of the Romberg's Balance Test With the CvMob Software
|
0.004 Centimeters
Standard Deviation 0.002
|
0.12 Centimeters
Standard Deviation 0.1
|
PRIMARY outcome
Timeframe: 5 minutesPopulation: Patients diagnosed with fibromyalgia according to the criteria of the American College of Rheumatology (n=40).
Subjects were instructed to walk on a 4 meters carpet at their normal walking step, with shocks and with flexed arms positioned on the abdomen. Optical markers were attached at the following three body positions: area between the lateral condyle of the femur and the fibular head, great trochanter and lateral malleolus. Subject's motion was digitally recorded with a video camera at 210 frames per second (CasioExilimEX-FS10). The camera was positioned at a distance of 4 meters from the carpet to visualize changes in position, velocity and anatomical points along the x-axis. It was calculated the stride length by an open- source software for computer vision analysis of human movement.
Outcome measures
| Measure |
Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform, on January 18, 2017
|
Control Group
n=20 Participants
No intervention arm
|
|---|---|---|
|
Gait Task
|
0.9 Meters
Standard Deviation 0.2
|
1.1 Meters
Standard Deviation 0.3
|
PRIMARY outcome
Timeframe: 5 minutesPopulation: Patients diagnosed with fibromyalgia according to the criteria of the American College of Rheumatology (n=40).
The Fibromyalgia Impact Questionnaire (FIQ) is an assessment and evaluation instrument developed to measure fibromyalgia (FM) patient status, progress and outcomes. It has been designed to measure the components of health status that are believed to be most affected by fibromyalgia. The FIQ is a self administered instrument that takes approximately 5 minutes to complete. The directions are simple and the scoring is self-explanatory. The FIQ is scored in such a way that a higher score indicates a greater impact of the syndrome on the person. Each of the 10 items has a maximum possible score of 10. Thus the maximum possible score is 100. The average FM patient scores about 50, severely afflicted patients are usually 70 plus.
Outcome measures
| Measure |
Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform, on January 18, 2017
|
Control Group
n=20 Participants
No intervention arm
|
|---|---|---|
|
Fibromyalgia Impact Questionnaire (FIQ)
|
69.3 Units on a scale
Standard Deviation 15.2
|
81.7 Units on a scale
Standard Deviation 6.6
|
PRIMARY outcome
Timeframe: 5 minutesPopulation: Patients diagnosed with fibromyalgia according to the criteria of the American College of Rheumatology (n=40).
Each participant was asked to indicate their current level of pain using a 20 cm VAS that ranged from 0 (no pain) to 100 (highest level of pain).
Outcome measures
| Measure |
Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform, on January 18, 2017
|
Control Group
n=20 Participants
No intervention arm
|
|---|---|---|
|
Visual Analogue Pain Scale (VAS)
|
71.2 units on a scale
Standard Deviation 7.9
|
78 units on a scale
Standard Deviation 5.2
|
PRIMARY outcome
Timeframe: 10 minutesPopulation: Patients diagnosed with fibromyalgia according to the criteria of the American College of Rheumatology (n=40).
The Quality of Life Index (QLI) is a self-report questionnaire that measures perceived health-related quality of life. We used the total score of QLI. Its scale is scored by simply adding the score on each item. The range of scores is between 15 to 105, with a higher score or number being indicative of a higher quality of life. An average total rating for a healthy person is usually around 90, whereas a low quality of life measures around 15.
Outcome measures
| Measure |
Whole Body Vibration Plat
n=20 Participants
An arm type in which a group of patients with fibromyalgia receives an intervention based on the use of a whole body vibration platform, considered to be effective by clinical evidence.
Whole body vibration platform: A neuromuscular treatment using a rotational whole body vibration platform, on January 18, 2017
|
Control Group
n=20 Participants
No intervention arm
|
|---|---|---|
|
Quality of Life Index (QLI)
|
5.0 units on a scale
Standard Deviation 0.9
|
3.8 units on a scale
Standard Deviation 0.8
|
Adverse Events
Whole Body Vibration Plat
Control Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place